IPO Update: With Just Two Small Offerings In Q2, What’s Next?

Seven US Launches In First Half Vs. 12 In H1 2024

 
• By Mandy Jackson
  
Biopharma firms are feeling blue with the IPO window essentially closed for now (Shutterstock)
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Financing

More from Business